Indole-3-carboxaldehyde
|
Basic information |
| Metabolite name | Indole-3-carboxaldehyde |
 | HMDB0029737 |
 |
C08493 |
 |
10256 |
| Synonyms | 1H-Indole-3-carboxaldehyde; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | Indole-3-carboxaldehyde |
| HMDB0029737 |
|
C08493 |
|
10256 |
| Synonyms | 1H-Indole-3-carboxaldehyde; |
| No. of studies | 5 |
|
Relationship between Indole-3-carboxaldehyde and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1010 | Type1 | CUMS group vs. control group | Faece | ICR mouse | Up |
| Study M1063 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M720 | Type1 | CUMS susceptible group vs. control group | Habenula | Sprague-Dawley rat | Down |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M942 | Type1 | CUMS group vs. control group | Serum | C57BL/6 mouse | Down |
| Study M942 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Serum | C57BL/6 mouse | Up |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Faece | C57BL/6 mouse | Up |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Hippocampus | C57BL/6 mouse | Up |